Stocklytics Platform
Asset logo for symbol RPTX
Repare Therapeutics
RPTX46
$1.32arrow_drop_up0.37%$0.00
Penny Stock
Asset logo for symbol RPTX
RPTX46

$1.32

arrow_drop_up0.37%

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Repare Therapeutics (RPTX) Stocklytics Forecast

Repare Therapeutics Inc. (RPTX) is a biotechnology company focused on developing precision oncology drugs. The company utilizes its proprietary SNIPRx platform to identify and develop small molecule inhibitors that target specific vulnerabilities in cancer cells. With a strong pipeline and promising preclinical data, Repare Therapeutics has gained attention from investors and analysts alike.
Looking ahead, the stock price of Repare Therapeutics Inc. (RPTX) is expected to experience significant growth in the coming years. With several key milestones on the horizon, including clinical trial updates and potential regulatory approvals, the company is well positioned for success. Analysts predict that the stock price could reach new heights by 2023.
add Repare Therapeutics  to watchlist

Keep an eye on Repare Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Repare Therapeutics (RPTX) stock?

Analysts have set a target price of $22.76 for Repare Therapeutics (RPTX), based on forecasts from 17 analysts. The predicted price range extends from a high of $47 to a low of $10. This represents a potential increase of up to 3.45K% and a decrease of 654.72% from the current price of $1.32. These forecasts are as of 2020 Jul 14.
help

What are the analyst ratings for Repare Therapeutics (RPTX) stock?

The analyst ratings for Repare Therapeutics (RPTX) are distributed as follows: 1 analysts recommend buying, 1 have a neutral stance, and 0 suggest selling. There is a split consensus, with equal support for two of the rating categories. These ratings indicate the general sentiment among the analysts covering Repare Therapeutics .
help

What is the AI price prediction for Repare Therapeutics (RPTX) stock?

At present, there is no AI or machine-learning-based price prediction available for Repare Therapeutics (RPTX) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level